Senior officials from the Dept of Pharma met their DIPP counterparts last week to enlist support for the proposal to avoid further delay in...

The government has recently stopped giving permission to foreign companies and overseas investors to buy into Indian drugmakers till clear ...

"...until there is a significant breakout, there is not much point in taking a position in a stock like Plethico."

Usually cos with weak financials offer higher returns on FDs; check the credit ratings before you put money in a company FD.

With interest rates inching up, company deposits and bonds have caught their attention. And guess what? They really have a lot to choose fr...

The company had posted a net profit of Rs 91.37 crore in the same period last fiscal, Plethico Pharmaceuticals said.

Plethico is one of those new age companies, which is into nutraceuticals apart from the allopathic drugs that they have been into.

Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, aptartindia.com in a chat with ET Now talks about Plethico Pharma.

Plethico Pharma, a small-cap pharma company manufacturing nutraceuticals and over-the-counter products, has witnessed a gradual rise in its...

Plethico Pharmaceuticals said it is looking at trimming its Contract Research and Manufacturing Services business.

Emkay Research has recommended ‘buy’ on Plethico Pharmaceutical for a target price of Rs 569. The stock currently trades at 9.9 times 2007-...

Plethico Pharmaceuticals subsidiary, Nutra Acquisition has completed by tender offer the acquisition of Natrol in accordance with the merge...

Plethico Pharmaceuticals on Monday said it will acquire US-based Natrol Inc for 80.7 million dollars (Rs 317.07 crore) to consolidate its p...

Plethico Pharmaceuticals Ltd has raised $75 million via foreign currency convertible bonds.

Corporates are likely to raise around Rs 35,000 crore from the initial public offerings (IPOs) in the primary market during the current fis...